Drug intelligence / Profile preview

Easyderm

Development stage
Unknown
Lead developer
EZDERM
Modality
Small Molecules
Administration
Topical
01

Overview

Easyderm is a brand name primarily associated with topical formulations of clobetasol propionate, a super-high potency (Group I) corticosteroid used for the treatment of severe inflammatory skin conditions. It is indicated for the relief of pruritic and inflammatory manifestations of corticosteroid-responsive dermatoses, such as psoriasis, recalcitrant eczemas, and lichen planus. Clobetasol propionate functions as an agonist of the glucocorticoid receptor; upon binding, it translocates to the nucleus where it modulates gene expression, leading to the induction of lipocortins. These proteins inhibit phospholipase A2, thereby blocking the release of arachidonic acid and the subsequent synthesis of inflammatory mediators like prostaglandins and leukotrienes. This mechanism results in potent anti-inflammatory, antipruritic, and vasoconstrictive actions. It is important to note that Easyderm is also a prominent brand for hydrocolloid wound dressings manufactured by Daewoong Pharmaceutical, which are classified as medical devices rather than pharmaceutical drugs.

Brand names
Easyderm
Other names
clobetasol propionate
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on Easyderm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Easyderm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call